Human Parvovirus and giant cell arteritis: a selective arteritic impact?

Area of Science:

• Epidemiology
• Virology
• Rheumatology

Background:

• Previous studies indicated a correlation between human Parvovirus (HPV) epidemics and peak incidences of giant cell arteritis (GCA).
• Giant cell arteritis encompasses temporal arteritis (TA) and polymyalgia rheumatica (PMR).

Purpose of the Study:

• To investigate the incidence of GCA, specifically the ratio of TA to PMR, before and after a major human Parvovirus epidemic in 1994.
• To determine if the epidemic influenced the TA/PMR ratio and identify geographical patterns.

Main Methods:

• Analysis of clinical data from the National Patient Register.
• Comparison of GCA incidence rates and the TA/PMR ratio in the periods preceding and following the 1994 HPV epidemic.
• Geographical analysis of the TA/PMR ratio changes relative to the epidemic's epicenter.

Main Results:

• A significant inversion of the TA/PMR ratio was observed in the 12 months post-epidemic.
• The inversion was primarily driven by an increase in TA incidence.
• The most pronounced changes in the TA/PMR ratio occurred in regions identified as the epidemic's epicenter.

Conclusions:

• The study provides further epidemiological evidence supporting a link between human Parvovirus epidemics and increased giant cell arteritis incidence.
• The findings suggest that HPV may act as a potential trigger for temporal arteritis.
• Geographical clustering of the effect highlights the localized impact of the viral epidemic on GCA presentation.